国际皮肤性病学杂志    2001 27 (6): 349-352   ISSN: 2096-5540  CN: 32-1880/R   汗孔角化症的病谱及遗传学研究进展 张正华综述1, 刘维达审校2 1. 中国医学科学院皮肤病研究所; 2. 中国协和医科大学皮肤病研究所 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Schamroth JM,Zlotogorski A,Gilead L.Porokeratosis of Mibelli:Overviewand review of the literature.Acta Derm Venerrol (Stockh),1997,77(3):207-213. [2] Matsushita S,Kanekura T,Kanzaki T.A case of disseminated superficialactinic porokeratosis subsequent to renal transplantation.J Dermatol,1997,24(2):110-112. [3] Romani J,Pujol RM,Casanova JM,et al.Disseminated superficial poro-keratosis developing after electron-beam total skin irradiation for mycosisfungoides.Clin Exp Dematot.1996,21 (4):310-312. [4] Park BS.Moon SE,Kim JA.Disseminated superficial porokeratosis in apatient with chronic liver disease.J Dermatol,1997,24(7):485-487. [5] Rodriguez EA,Jakubowicz S,Chinchilla DA,et al.Porokeratosis of Mibelliand HIV-infection.Int J Dematol,1996,35(6):402-404. [6] Dover JS,Phillips TJ,Bums DA,et al.Disseminated superficial actinic porokeratosis.coexistence with other porokeratotic variants.Arch Dermatol.1986,122(8):887-889. [7] Dippel E,Haas N,Czametzki BM.Porokeratosis of mibelli associated with active chronic hepatitis and vitiligo.Acta Derm Venereol (Stockh),1994,74(6):463-464. [8] Tsambaos D,Spiliopoulos T.Disseminated superficial porokeratosis:com plete remission subsequent to discontinuation of immuosuppression.J.AmAcad Dermatol,1993.28(4):651-652. [9] Xia JH,Yang YF,Deng H,et al.Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1.J InvestDermatol.2000,114(6):1071-1074. [10] Happle R.Cancer proneness of linear porokeratosis may be explained by allelic loss.Dermatolog.,1997.195(1):20-25. [11] McNutt NS.Saenz-Santamaria C,Volkenandt M,et al.Abnomalities of p53 protein expression in cutaneous disorders.Arch Dermatol,1994,1302):225-232. [12] Nelson C,CowlperS,Morgan M.p53,mdm-2,and p21 waf-l in the poro keratoses..Am J Dermatopathol,1999,21 (5):420-425. [13] Magee JW,McCalmont TH,LeBoit PE,et al.Overexpression of p53 tumor suppressor protein in porokeratosis.Arch Dermatol,1994,130 (2):187-190. [14] Ninomiya Y,Urano Y,Yoshimoto K,et al.p53 gene mutation analysis inporokeratosis and porokeratosis-associated squamous cell carcinoma.J Der-matol Sci,1997,14(3):173-178. [15] Sakuntabhai A,Ruiz-Perez V,Carter S,et al.Mutations in ATP2A2,en-coding a Ca2 + pump,cause Darier Disease.Nat Genet,1999,21(3):271-277. [16] Ringpfeil F,Raus A.DiGiovanna JJ,et al.Darier disease-novel mutationsin ATP2A2 and genotype-phenotype correlation.Fxp Dermatol,2001,10(1):19-27. [17] Richard G,Smith LE,Bailey RA,et al.Mutations in the human connexingene GJB3 cause erythrokeratodema varialilis.Nat Genet,1998,20(4):366-369. [18] Happle R.A rule conceming the segmental manifestation of autosomal dom inant skin disorders.Arch Dermatol,1997,133(12):1505-1509. [19] Freyschmidt-Paul P,Hoffmann R,Konig A,et al.Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis:report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders.J Am Acad Dermatol,1999,41 (4):644-647. [20] Bencini PL,Tarantino A,Grimalt R,et al.Porokeratosis and immunosuppression.Br J Dermatol,1995,132(1):74-78. 通讯作者: